Gain Therapeutics Inc (GANX) financials · $53.0M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Gain Therapeutics Inc (GANX) $53.0M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$18.7M | -$20.4M |
| Net Income | -$20.2M | -$20.4M |
| EPS (Diluted) | -$0.61 | -$0.89 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $22.8M | $12.1M |
| Current Assets | $22.2M | $11.6M |
| Cash & Equivalents | $20.8M | $10.4M |
| PP&E | $74.9K | $103.6K |
| Total Liabilities | $4.25M | $4.78M |
| Current Liabilities | $3.35M | $3.91M |
| Short-term Debt | $100.9K | $110.2K |
| Long-term Debt | $300.1K | $328.3K |
| Total Debt | $401.0K† | $438.5K† |
| Shareholders' Equity | $18.6M | $7.34M |
| Retained Earnings | -$81.2M | -$60.8M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$18.5M | -$18.9M |
| CapEx | N/A | $22.5K |
| Investing Cash Flow | N/A | $4.98M |
| Financing Cash Flow | $28.4M | $13.0M |
| Net Change in Cash | $10.5M | -$1.41M |
| Free Cash Flow | N/A | -$18.9M |
FAQ
What is GANX P/E and revenue?
Gain Therapeutics Inc (GANX) $53.0M cap.
What is GANX revenue?
GANX income-statement cache has no revenue figure yet.
Is GANX profitable?
Gain Therapeutics Inc last cached net income is -$20.2M (FY2025).
What are GANX total assets?
Gain Therapeutics Inc last cached total assets are $22.8M (FY2025).
What is GANX free cash flow?
No cached cash-flow row for GANX yet.
Not investment advice. Cached statements, not a live tape.